Matches in SemOpenAlex for { <https://semopenalex.org/work/W117584151> ?p ?o ?g. }
- W117584151 endingPage "13" @default.
- W117584151 startingPage "6707" @default.
- W117584151 abstract "Urinary prostate-specific antigen (uPSA) can be used as additional parameter of benign prostatic hyperplasia (BPH) progression.From January 2001 to December 2011, uPSA was determined in 265 patients with benign prostate. Based on total prostate volume (TPV), the patients with benign prostate were divided in two groups: TPV < 31 mL and TPV ≥ 31 mL. Additional three groups were formed upon MTOPS study criteria: non- progressive BPH group (TPV < 31 mL, PSA < 1.6 ng/mL, age < 62 yrs), intermediate group (one, or two parameters {TPV, PSA, age} increased) and progressive BPH group (TPV ≥ 31 ml, PSA ≥ 1.6 ng/mL, age ≥ 62 yrs).Average uPSA values in the groups TPV < 31 mL and TPV ≥ 31 mL were 119.3 ± 124.5 and 255.5 ± 204.9 ng/mL, respectively and they were significantly different (p < 0.0001). Average uPSA values in the non- progressive BPH group, intermediate group and progressive BPH group were 86.8 ± 82.4 ng/mL, 166.6 ± 164.9 ng/mL and 274.9 ± 208.3 ng/mL, respectively and they were significantly different (p < 0.0001). The level of uPSA correlated significantly with TPV (r = 0.32, p < 0.0001). The cut off uPSA level of 150 ng/mL discriminates the patients with non-progressive BPH and progressive BPH with specificity of 0.83 and sensitivity of 0.67.The level of uPSA reflects prostatic hormonal activity and correlates with TPV, PSA and age. UPSA level ≥ 150 ng/mL can be used as additional predictive parameter of BPH progression." @default.
- W117584151 created "2016-06-24" @default.
- W117584151 creator A5012273589 @default.
- W117584151 creator A5025387975 @default.
- W117584151 creator A5041828804 @default.
- W117584151 creator A5043197963 @default.
- W117584151 creator A5067092661 @default.
- W117584151 creator A5083482517 @default.
- W117584151 creator A5085568835 @default.
- W117584151 date "2013-04-01" @default.
- W117584151 modified "2023-09-23" @default.
- W117584151 title "Urinary prostate-specific antigen: predictor of benign prostatic hyperplasia progression?" @default.
- W117584151 cites W102221133 @default.
- W117584151 cites W112624127 @default.
- W117584151 cites W1490948691 @default.
- W117584151 cites W16556138 @default.
- W117584151 cites W169007637 @default.
- W117584151 cites W1773621349 @default.
- W117584151 cites W1913845192 @default.
- W117584151 cites W1919817814 @default.
- W117584151 cites W1924428619 @default.
- W117584151 cites W1936521941 @default.
- W117584151 cites W1963499652 @default.
- W117584151 cites W1966848654 @default.
- W117584151 cites W1968473988 @default.
- W117584151 cites W1969803136 @default.
- W117584151 cites W1974940609 @default.
- W117584151 cites W1974968903 @default.
- W117584151 cites W1979870734 @default.
- W117584151 cites W1981369942 @default.
- W117584151 cites W1994357428 @default.
- W117584151 cites W1997757226 @default.
- W117584151 cites W1997761001 @default.
- W117584151 cites W2017450034 @default.
- W117584151 cites W2019725795 @default.
- W117584151 cites W2034266081 @default.
- W117584151 cites W2041542039 @default.
- W117584151 cites W2043981027 @default.
- W117584151 cites W2046325786 @default.
- W117584151 cites W2057627532 @default.
- W117584151 cites W2058725198 @default.
- W117584151 cites W2061317403 @default.
- W117584151 cites W2063922017 @default.
- W117584151 cites W2064180812 @default.
- W117584151 cites W2077100052 @default.
- W117584151 cites W2082709973 @default.
- W117584151 cites W2085663621 @default.
- W117584151 cites W2106455438 @default.
- W117584151 cites W2106501078 @default.
- W117584151 cites W2108847543 @default.
- W117584151 cites W2120890122 @default.
- W117584151 cites W2122680090 @default.
- W117584151 cites W2125594798 @default.
- W117584151 cites W2126369504 @default.
- W117584151 cites W2141257705 @default.
- W117584151 cites W2148027243 @default.
- W117584151 cites W2152487270 @default.
- W117584151 cites W2167083509 @default.
- W117584151 cites W2171367875 @default.
- W117584151 cites W2367162723 @default.
- W117584151 cites W2397311089 @default.
- W117584151 cites W2406121184 @default.
- W117584151 cites W2411108588 @default.
- W117584151 cites W2411831826 @default.
- W117584151 cites W2422108216 @default.
- W117584151 cites W270393398 @default.
- W117584151 cites W2766237802 @default.
- W117584151 cites W65134806 @default.
- W117584151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23587511" @default.
- W117584151 hasPublicationYear "2013" @default.
- W117584151 type Work @default.
- W117584151 sameAs 117584151 @default.
- W117584151 citedByCount "3" @default.
- W117584151 countsByYear W1175841512015 @default.
- W117584151 countsByYear W1175841512019 @default.
- W117584151 countsByYear W1175841512023 @default.
- W117584151 crossrefType "journal-article" @default.
- W117584151 hasAuthorship W117584151A5012273589 @default.
- W117584151 hasAuthorship W117584151A5025387975 @default.
- W117584151 hasAuthorship W117584151A5041828804 @default.
- W117584151 hasAuthorship W117584151A5043197963 @default.
- W117584151 hasAuthorship W117584151A5067092661 @default.
- W117584151 hasAuthorship W117584151A5083482517 @default.
- W117584151 hasAuthorship W117584151A5085568835 @default.
- W117584151 hasConcept C121608353 @default.
- W117584151 hasConcept C126322002 @default.
- W117584151 hasConcept C126894567 @default.
- W117584151 hasConcept C147483822 @default.
- W117584151 hasConcept C203014093 @default.
- W117584151 hasConcept C2776235491 @default.
- W117584151 hasConcept C2777562237 @default.
- W117584151 hasConcept C2780192828 @default.
- W117584151 hasConcept C2781406297 @default.
- W117584151 hasConcept C71924100 @default.
- W117584151 hasConcept C77411442 @default.
- W117584151 hasConceptScore W117584151C121608353 @default.
- W117584151 hasConceptScore W117584151C126322002 @default.
- W117584151 hasConceptScore W117584151C126894567 @default.